Collectively, these findings indicate that matrix stiffness-induced MAPK8 activity promote breast cancer progression and suggest that MAPK8 signaling represents a candidate for the development of new breast cancer treatment modalities. This evidence concerns the gene MAPK8 and breast cancer.